Dentsply Sirona in its review of strategic alternatives for Wellspect Healthcare

On February 11, 2025, Dentsply Sirona (Nasdaq: XRAY) announced that it has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business.  Wellspect is a leading provider of continence care products with an over 40-year history.

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Dentsply Sirona.